Gangadi Madhukar Reddy, a promoter of medplus health services , has confirmed that he has not created any encumbrance on the shares held by him during the Financial Year 2025-26. The declaration, submitted to the stock exchanges on April 4, 2026, assures shareholders regarding the status of the promoter's shareholding and confirms that no new charges or liens have been placed on the shares other than those previously disclosed.

The disclosure was made in compliance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011. This regulation requires promoters to disclose any encumbrance on their shareholdings to ensure transparency for investors.

Declaration Details

The communication was addressed to the Audit Committee of MedPlus Health Services Limited and the stock exchanges. It explicitly states that the promoter has not made any encumbrance on the shares of MedPlus Health Services Limited, either directly or indirectly, other than those that were already disclosed during the specified financial year.

The document was submitted to BSE Limited and the National Stock Exchange of India Limited for their records and to inform the investing public.

MedPlus Health Services Limited has announced key leadership changes following its board meeting on May 20, 2026. The board approved the appointment of two Non-Executive Independent Directors and the re-appointment of the Managing Director, all subject to shareholder approval.

Board Appointments

Based on the recommendation of the Nomination and Remuneration Committee, the board appointed Mr. Ajit Pandurang Rangnekar and Mr. Mohankrishna Reddy Arvabumi as Additional Directors designated as Non-Executive Independent Directors. Their appointments are effective May 20, 2026, for a first term of five years.

Mr. Rangnekar brings over 50 years of experience across manufacturing, services, and consulting, while Mr. Arvabumi offers over three decades of expertise in finance and strategy, having held senior roles at institutions like Indian Bank and ANZ Grindlays Bank.

Managing Director Re-appointment

The board approved the re-appointment of Mr. Gangadi Madhukar Reddy as Managing Director for a period of five years commencing August 03, 2026. A promoter of the company, Mr. Reddy has been associated with MedPlus since its inception and holds an MBA from The Wharton School.

The company affirmed that none of the appointed directors are debarred from holding the office of director by any SEBI order or other authority.